Reading time: 5 minutes Varshit Dusad A cancer diagnosis is generally perceived to be a death sentence. With millions of people dying of cancer every year, this does not seem to be at all outrageous. However, researchers all over the world, in academia and industry alike, have been relentlessly pursuing novel therapies and drugs to... Continue Reading →
Malignant Costs of Cancer Care
Reading time: 6 minutes Nisitha Sengottuvel So far, a lot of the articles we have been discussing here on Oncobites have been revolving around bench research regarding cancer biology and therapeutics. On the public health side of cancer care, there are a lot of emerging fields: one of which investigates the economic burden of cancer... Continue Reading →
Fasting Away Tumors (With a Little Help From Metformin)
Reading time: 4 minutes Sara Musetti The world of drug discovery is a frustrating, delicate world. Scientists spend years working on fine-tuning molecules to improve their function, make them safer, or even just make them easier to give to patients. We have a catalog of drugs that work on single, specific proteins only found in... Continue Reading →
Colorectal cancer is on the rise in adults < 50 years old
Reading time: 4 minutes Morgan McSweeney Note: Throughout this article, I will use phrases such as "patients with overweight/obesity" instead of "overweight/obese patients." This is because the field is trying to move away from using disease states as descriptors. Another example would be a preference for saying "patients with diabetes" instead of "diabetics." I know... Continue Reading →